Post Marketing Surveillance of Effectiveness (All-Cause Mortality) of Posaconazole Injection and Tablet Treatment of Invasive Aspergillosis in Chinese patients (MK-5592-141)

First published 18/01/2024

Last updated 14/02/2025

EU PAS number:

EUPAS108481

Study

Ongoing

Documents

Study protocol

Initial protocol

MK-5592-141-00-v1-Protocol_final-redaction

English (771.06 KB - PDF)View document

Updated protocol

MK-5592-141-01-v1-Protocol_final-redaction.pdf

First published: 09/01/2025

English (1.74 MB - PDF)View document

Study results

Study report

Other information

Secondary tabs